Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoride for treating postmenopausal osteoporosis.

D Haguenauer1, V Welch, B Shea

  • 1Clinical Epidemiologist, 135 Riverdale Avenue, Ottawa, Ontario, Canada, K1S-1R1. HaguenauerLTD@home.com

The Cochrane Database of Systematic Reviews
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

Communications medicine·2026
Same author

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors.

Seminars in arthritis and rheumatism·2025
Same author

Early COVID-19 pandemic modeling: Three compartmental model case studies from Texas, USA.

Computing in science & engineering·2022
Same author

A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

The ASAS-OMERACT core domain set for axial spondyloarthritis.

Seminars in arthritis and rheumatism·2021
Same author

<i>trips4health</i>: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain.

Contemporary clinical trials communications·2020
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Fluoride therapy increases bone mineral density in postmenopausal women but does not reduce vertebral fractures. Higher doses increase non-vertebral fracture and gastrointestinal side effect risks.

Area of Science:

  • Osteoporosis Research
  • Pharmacological Interventions
  • Bone Health

Background:

  • Postmenopausal osteoporosis is a significant health concern.
  • Effective treatments are needed to reduce fracture risk.

Purpose of the Study:

  • To evaluate fluoride therapy's efficacy in treating bone loss.
  • To assess its impact on vertebral and non-vertebral fractures.
  • To determine the incidence of side effects in postmenopausal women.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) up to December 1998.
  • Data extraction and quality assessment by two independent reviewers.
  • Meta-analysis using random effects models for heterogeneous data.

Related Experiment Videos

Main Results:

  • Fluoride therapy significantly increased lumbar spine bone mineral density (BMD) by 8.1% at 2 years and 16.1% at 4 years.
  • No significant reduction in vertebral fractures was observed at 2 or 4 years.
  • Increased risk of non-vertebral fractures and gastrointestinal side effects at 4 years, particularly with high-dose, non-slow-release fluoride.

Conclusions:

  • Fluoride increases lumbar spine BMD but does not reduce vertebral fracture rates.
  • Higher fluoride doses elevate risks of non-vertebral fractures and gastrointestinal issues without improving vertebral fracture outcomes.